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1. Introduction 
Antibacterial chemotherapy has been applied in aquaculture for over 60 years. The 
discovery of antibacterials changed the treatment of infectious diseases, leading to a 
dramatic reduction in morbidity and mortality, and contributing to significant advances in 
the health of the general population. Antibacterials are used both prophylactically, at times 
of heightened risk of disease and therapeutically, when an outbreak of disease occurs in the 
system. The removal of antibacterials from fish medicine would cause great welfare 
problems. There are many antibacterial drugs for animal health. However, pharmacological 
research on aquaculture drugs has focused mainly on a few antibacterials widely used in 
aquaculture. It is well recognised that the issues relating to antibacterial use in animal food 
are of global concern. Currently, there is a general perception that veterinary medicines, and 
in particular antibacterials, have not always been used in a responsible manner. In some 
cases, rather than providing a solution, chemotherapy may complicate health management 
by triggering toxicity, resistance, residues and occasionally public health and environmental 
consequences. As a result, authorities have introduced national regulations on the use of 
antibacterials. 
2. Antibacterial use in aquaculture 
Aquaculture continues to be the fastest growing animal food producing sector, and 
aquaculture accounted for 46% of total food fish supply (FAO, 2011). The intensification of 
aquaculture has led to the promotion of conditions that favour the development of a 
number of diseases and problems related to biofouling. It is worth remembering the age-old 
adage that "prevention is better than cure?" and certainly it is possible to devote more 
attention to preventing the occurrence of disease in fish. Fish may be reared under ideal 
conditions, in which case the stock are inevitably in excellent condition and without signs of 
disease (Austin & Austin, 2007). However, disease is a component of the overall welfare of 
fish (Bergh, 2007). Consequently, a wide range of chemicals are used in aquaculture, 
including antibacterials, pesticides, hormones, anaesthetics, various pigments, minerals and 
vitamins, although not all of them are antibacterial agents. As is the case in terrestrial animal 
production, antibacterials are also used in aquaculture in attempts to control bacterial 
disease (Burka et al., 1997; Horsberg, 1994; Defoirdt et al., 2011). Usage patterns also vary 
between countries and between individual aquaculture operations within the same country. 
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Antibacterials are among the most-used drugs in veterinary medicine (Sanders, 2005). The 
principal reasons behind the control of infectious diseases in hatcheries are to prevent losses in 
production; to prevent the introduction of pathogens to new facilities when eggs, fry, or 
broodstock are moved; to prevent the spread of disease to wild fish via the hatchery effluent or 
when hatchery fish are released or stocked out; and to prevent the amplification of pathogens 
already endemic in a watershed (Phillips et al., 2004; Winton, 2001; Lupin, 2009). Antibacterial 
usage requires veterinary prescription in aquaculture as with usage in terrestrial animals 
(Sanders, 2005; Prescott, 2008; Rodgers & Furones, 2009). We have limited data about 
antibacterial use in world aquaculture. For most of the species farmed, we also lack adequate 
knowledge of the pharmacokinetics (PK) and pharmacodynamics (PD) of administration 
(Smith et al., 2008). Along with widespread use comes a growing concern about irresponsible 
use, such as the covert use of banned products, misuse because of incorrect diagnose and 
abuse owing to a lack of professional advice. That said, there are still not enough approved 
products for a range of species and diseases in aquaculture (FAO, 2011). 
Antibacterials are drugs of natural or synthetic origin that have the capacity to kill or to 
inhibit the growth of micro-organisms. Antibacterials that are sufficiently non-toxic to the 
host are used as chemotherapeutic agents in the treatment of infectious diseases amongst 
humans, animals and plants (Table 1). Drug choices for the treatment of common infectious 
diseases are becoming increasingly limited and expensive and, in some cases, unavailable 
due to the emergence of drug resistance in bacteria that is threatening to reverse much of the 
medical progress of the past 60 years (FAO, 2005). In aquaculture, antibacterials have been 
used mainly for therapeutic purposes and as prophylactic agents (Shao, 2001; Sapkota et al., 
2008; FAO, 2005). The voluntary use of antibacterials as growth promoters in any aspect of 
aquaculture is generally rare. Prophylactic treatments, when they are employed, are mostly 
confined to the hatchery, the juvenile or larval stages of aquatic animal production. 
Prophylactic treatments are also thought to be more common in small-scale production 
units that cannot afford, or cannot gain access to, the advice of health care professionals. 
There are no antibacterial agents that have been specifically developed for aquacultural use 
and simple economic considerations suggest that this will always be the case (Smith et al., 
2008; Rodgers & Furones, 2009). Despite the widespread use of antibacterials in aquaculture 
facilities, limited data is available on the specific types and amounts of antibacterials used 
(Sapkota et al., 2008; Heuer et al., 2009). General considerations in the selection and use of 
antibacterial drugs are given by Figure 1. (Walker & Giguére, 2008). Treatment options will 
be different for animals that are held in net pens at sea as opposed to those held in an indoor 
facility or an aquarium. A treatment must also be feasible: an appropriate treatment route 
for aquarium fish or selected broodstock individuals may be cost- or labour-prohibitive in 
commercial aquaculture ventures. The stress associated with treatments must be balanced 
with the need for and the expected benefits of treatment (Smith et al., 2008). Also, before 
making a decision to treat a group of fish, the following questions should be asked (Winton, 
2001): 
1. Does the loss-rate, severity or nature of the disease warrant treatment? 
2. Is the disease treatable, and what is the prognosis for successful treatment? 
3. Is it feasible to treat the fish where they are, given the cost, handling, and prognosis? 
4. Is it worthwhile to treat the fish or will the cost of treatment exceed their value? 
5. Are the fish in a good enough condition to withstand the treatment? 
6. Will the treated fish be released or moved soon, and is adequate withdrawal or 
recovery time available? 
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Antibacterial 
class 
Mode / mechanism
of action
Mechanisms of 
resistance
Multiple 
resistancea
PK-PD 
relationshipb 
     
ß-Lactams 
(penicillins, 
cephalosporins, 
and 
carbapenems) 
Bactericidal. Inhibition 
of the penicillin binding 
proteins (PBPs) located 
on the cytoplasmic 
membrane 
ß-lactamase 
production, PBPs 
modifications, 
reduced permeability, 
and efflux 
Yes Time-
dependent 
Aminoglycosides
(streptomycin 
and neomycin) 
Bactericidal. Protein 
synthesis inhibition 
through binding to the 
30s subunit of the 
ribosome 
Decreased 
permeability, efflux, 
modification of 
enzymes, and target 
(ribosome) 
modification 
Yes Concentration
-dependent 
Macrolides 
(erythromycin, 
tylosin and 
spiramycin) 
Bacteriostatic. Protein 
synthesis inhibition 
through binding to the 
50s subunit of the 
ribosome 
Target (ribosome) 
modification of 
enzymes, decreased 
permeability and 
efflux 
Yes Time-
dependent 
     
Fluoroquinolones
(enrofloxacin 
and 
ciprofloxacin) 
Bactericidal. Inhibition 
of DNA gyrase and 
topoisomerase 
Target point 
mutations decreased 
permeability, efflux 
and plasmid 
mediated mechanism
Yes Concentration
-/time- 
dependent 
Tetracyclines 
(oxytetracycline 
and 
chlortetracycline)
Bacteriostatic. Protein 
synthesis inhibition at 
the ribosomal level 
(interference with 
peptide elongation)
Efflux, drug 
detoxification, and 
ribosome 
modification 
Yes Time-
dependent 
Folate synthesis 
inhibitors 
(sulphonamides 
and ormetoprim)
Single bacteriostatic, 
combination 
bactericidal. Inhibition 
of dihydro-pteroate 
synthase and 
dihydrofolate reductase
Decreased 
permeability, 
formation of enzymes 
with reduced 
sensitivity to the 
drugs
Yes Concentration
-dependent 
     
Phenicols 
(florfenicol and 
chloramphenicol)
Bacteriostatic. Inhibit 
the peptidyltransferase 
reaction at the 50s 
subunit of the ribosome
Decreased target 
binding, reduced 
permeability, efflux 
and modifying 
enzymes 
Yes Time-
dependent 
aResistance to antibacterials belonging to different classes in at least one of the isolates. bRepresents a 
generalisation only, the actual relationship can be variable when an individual drug is involved. 
Table 1. Properties of the major classes of antibacterial agents (Modified from (Yan & 
Gilbert, 2004) and (Defoirdt et al., 2011)). 
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2.1 The pathogen and the host 
Organisms responsible for disease in aquatic species include fungi, bacteria, nematodes, 
cestodes and trematodes as well as parasitic protozoans, copepods and isopods. Some can 
cause death, while others may stress the affected animal to the point that it becomes more 
susceptible to additional diseases (Stickney, 2005). Disease forms a part of the lives of wild 
fish and farmed fish. Often, it is not cultured fish that are most susceptible, due to efficient 
prophylactic strategies and good culture practices. Unprotected wild fish, as exemplified in 
the case of salmon lice, will be more susceptible to infections and mortality (Bergh, 2007). 
The difference between health and disease typically depends on the balance between the 
pathogen and the host, and that balance is greatly influenced by environmental factors, such 
as temperature and water chemistry (Winton, 2001). The diagnostic techniques for 
pathogens that are used range from gross observation to highly technical bimolecular-based 
tools. Pathogen screening is another health management technique, which focuses on the 
detection of pathogens in subclinical or apparently healthy hosts (Subasinghe, 2009).  
 
 
Fig. 1. Some considerations in selecting and using antibacterial drugs (Walker & Giguére, 2008).  
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The primary pathogens in aquaculture are bacteria and viruses (Shao, 2001). More than 100 
bacterial pathogens of fish and shellfish have been reported (Alderman & Hastings, 1998; 
Winton, 2001). The artificially high host-densities associated with aquaculture are 
evolutionarily beneficial for pathogens (Bergh, 2007). Bacterial pathogens probably cause 
more disease problems overall than all other causes combined. In virtually every type of 
aquaculture, bacterial diseases rank number one amongst aetiological agents. In each type of 
culture, and for virtually every species, specific bacterial pathogens are responsible for 
serious disease problems. Gram-negative bacilli are the most frequent cause of bacterial 
diseases in finfish. Although only a few Gram-positive forms affect finfish, such bacteria 
cause serious diseases among crustaceans (Meyer, 1991; Rodger, 2010; Roberts, 2004). 
Whereas similar types of pathogens affect freshwater and marine fish, relatively few 
pathogens are transmissible from freshwater fish to marine fish, and vice versa (i.e. most 
pathogens affect either marine or freshwater fish, but not both). This is the rationale for why 
many freshwater pathogens can be treated with salt, and many marine pathogens can be 
treated with freshwater (Noga, 2010). Choosing the right drug depends in part on such fac-
tors as age, size and the housing of the animal. Common bacterial fish diseases, their 
definition, aetiology and treatment, as well as control issues, are resumed in Table 2.  
 
Disease / Aetiology Treatment and control 
Mycobacteriosis. Mycobacteriosis in fish is a chronic 
progressive disease caused by certain bacterial 
species within the genus Mycobacterium. 
Mycobacterium marinum, M. fortuitum, M. 
salmoniphilum and M. chelonae are all considered 
pathogenic for fish. All are aerobic, acid-fast, Gram-
positive and non-spore forming. 
There is no fully effective 
treatment. Therefore, the best 
course is to cull and disinfect the 
premises. Rifampicin in 
combination with tetracycline 
(Boos et al., 1995) and 
clarithromycin may reduce 
infection (Collina et al., 2002). 
Coldwater Diseases & Rainbow Trout Fry 
Syndrome (RTFS). Bacterial coldwater disease is a 
serious septicaemic infection of hatchery-reared 
salmonids, especially young coho salmon, which has 
also been referred to as peduncle disease. Flexibacter 
psychrophilus, Cytophaga psychrophila and 
Flavobacterium psychrophilum are all terms that have 
been used for the causal agents of these diseases. 
Most of the recent classificatory work indicates that 
Flavobacterium psychrophilum is the correct name for 
these bacteria. These bacteria are Gram-negative. 
Broad-spectrum antibacterials 
have been partially ineffective in 
controlling an outbreak, but the 
improvement of the 
environment and using 3-4 times 
the recommended doses of 
antibacterials have shown 
benefits (Bebak et al., 2007). 
Florfenicol also appears to be 
effective for recommended  
dose regimes.  
Bacterial Kidney Disease (BKD). A serious disease of 
freshwater and seawater fish, farmed and wild 
salmonids, that results in an acute to chronic systemic 
granulomatous disease. Renibacterium salmoninarum is 
a Gram-positive diplococcus that grows best at 15-
18°C, is causative agent of BKD and a significant 
threat to the healthy and sustainable production of 
salmonid fish worldwide (Wiens et al., 2008).  
Chemotherapy (erythromycin) 
provides limited and only 
temporary relief. The bacteria 
can survive and multiply within 
phagocytic cells. 
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Enteric Redmouth Disease (ERM). A bacterial 
septicaemic condition of farmed salmonids, and in 
particular rainbow trout. There are recent reports 
amongst channel catfish. Yersinia ruckeri is the causal 
agent and the Gram-negative, motile rod-shaped 
bacterium is catalase positive and oxidase negative. 
Several serotypes have been identified. 
Broad-spectrum antibacterials 
are effective in controlling an 
outbreak, although increasing 
antibacterial resistance is 
observed. The bacteria can 
survive and multiply within 
phagocytic cells (Tobback et al., 
2009; Rykaert et al., 2010).  
Furunculosis. Furunculosis is a fatal epizootic 
disease, primarily of salmonids. It also causes clinical 
diseases in other fish species, where it is named ulcer 
disease or carp erythrodermatitis. Aeromonas 
salmonicida is a Gram-negative bacteria. Atypical 
furunculosis is caused by a slower growing non-
pigmenting isolate, A. salmonicida achromogenes. 
Broad-spectrum antibacterials 
are effective in controlling an 
outbreak, but increasing 
antibacterial resistance is 
observed. 
Piscirickettsiosis. A disease of salmonids caused by 
Piscirickettsia salmonis and a significant disease 
problem in farmed marine salmonids. Piscirickettsia 
salmonis is a Gram-negative, acid-fast, non-motile, 
spherical to coccoid, non-capsulated (although often 
pleomorphic) organism.  
 
Broad-spectrum antibacterial 
therapy is used, although some 
resistance is developing. 
Outbreaks are usually associated 
with stressful events, such as 
algal blooms, sudden changes in 
the environment or grading.  
Bacterial Gill Disease (BGD). BGD is an important 
disease in farmed freshwater salmonids. The 
bacterium Flavobacterium branchiophila causes a 
chronic, proliferative response in gill tissue. 
Flavobacterium branchiophila is a Gram-negative, long, 
thin, filamentous rod. 
BGD usually responds well to 
antiseptic and surfactant baths, 
such as chloramine T and 
benzalkonium chloride. 
Providing adequate oxygen is a 
useful supportive therapy.  
Vibriosis. Vibriosis is the term most commonly used 
to describe infections associated with Vibrio spp. In 
recent years, vibriosis has become one of the most 
important bacterial diseases in marine-cultured 
organisms (Stabili et al., 2010). Vibrio anguillarum, V. 
ordalii and other Vibrio sp. may cause similar clinical 
signs in wild and farmed fish. It is Gram-negative, 
and has straight or slightly curved rods which are 
motile.  
 
Broad-spectrum antibacterials 
are effective in controlling an 
outbreak, but increasing 
antibacterial resistance is 
observed. Vaccines are widely 
used. Caprylic acid may be 
helpful as an alternative or as an 
adjunct to antibacterial 
treatment (Immanuel et al., 
2011).
Epitheliocystis. Epitheliocystis is a chronic and 
unique infection caused by the Chlamydia spp. 
organism and which results in hypertrophied 
epithelial cells - typically of the gills but sometimes 
also of the skin - or certain freshwater and marine 
fishes.  
Broad-spectrum antibacterials 
have been used with some 
degree of success, though the 
avoidance of infected fish 
should be adhered to at all costs. 
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Tenacibaculosis. An infection of marine fish by 
Tenacibaculum maritimum is common in farmed fish 
and many species. The bacteria appear to be 
opportunistic, commonly infecting fish after minor 
epidermal or epithelial trauma or irritation, and they 
can rapidly colonise such tissue. It is Gram negative, 
with slender bacilli which multiply in mats on the 
damaged tissue. 
Oral treatment with broad-
spectrum antibacterials is 
generally successful if the fish 
are maintained in a low-stress 
environment.  
 
Francisellosis. Francisellosis is the term used to 
describe infection associated with Francisella 
philomiragia subspecies noatunensis, which has emerged 
as a major pathogen of farmed cod. Francisella spp. is 
also a major pathogen of farmed tilapia. It is Gram- 
negative, with intracellular coccobacilli. 
There is no effective treatment 
due to the intracellular nature of 
the infection. Removal of the 
affected fish and the disinfection 
of the premises and equipment, 
and fallowing.  
Rainbow Trout Gastro-Enteritis (RTGE). RTGE is an 
enteric syndrome of freshwater farmed rainbow trout, 
reported in several European countries, and which 
results in significant economic loss and daily 
mortalities. It is not fully established and the role of 
the segmented filamentous bacteria remains unclear, 
as they are also found in apparently healthy fish. 
However, Candidatus arthromitis may have some role 
to play in the disease. This bacterium have not yet 
been cultured in vitro. 
Changing the diet-type or the 
addition of salt to the diet as 
well as broad-spectrum 
antibacterials all appear to be 
effective, once the disease is 
present. However, none appear 
to be preventative. Biosecurity is 
important in preventing the 
disease from entering a farm. 
Red Mark Syndrome (RMS) or Cold Water 
Strawberry Disease. RMS is an infectious dermatitis 
of rainbow trout which does not cause mortality but 
which presents as dramatic haemorrhagic marks on 
the skin. It is not fully established, although 
Flavobacterium psychrophilum and rickettsia-like 
organisms have been associated with it. 
The lesions will resolve 
eventually without treatment; 
however, broad-spectrum 
antibacterials do induce the 
rapid healing of the condition. 
The avoidance of any livestock 
from infected farms reduces the 
chance of the introduction of 
RMS onto a site. 
Table 2. Common bacterial fish diseases, their aetiology and treatment – control issues 
(Modified from (Rodger, 2010)).  
2.2 Antibacterial susceptibility testing of aquatic bacteria 
Resistance is a description of the relative insusceptibility of a microorganism to a 
particular treatment under a particular set of conditions. Therefore, it should be noted 
that resistance or at least the resistance level depends strongly upon the test type and test 
conditions, as well as the type of compound and its mode of action (Kümmerer, 2008). The 
empirical use of antibacterials should be avoided. The use of antibacterials should always 
be based upon an examination of the clinical case, the diagnosis of a bacterial infection 
and the selection of a clinically efficacious antibacterial agent. However, in certain 
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situations (such as when the animal is seriously ill or where there is an outbreak with a 
high mortality or a rapid spread) therapy may be initiated on the basis of clinical signs 
(Guardabassi & Kruse, 2008; Smith et al., 2008). The target organisms must be known or 
shown to be susceptible, and adequate concentrations must be shown to reach the target 
(Phillips et al., 2004). A definitive diagnosis requires the isolation and identification of the 
causative organism, preferably from three to five infected fish (Smith et al., 2008). Samples 
for a bacteriologic culture should be collected from the actual site of infection before 
administering an antibacterial drug (Walker & Giguére, 2008). Currently, a wide range of 
standardised methods are available (Smith et al., 2008; Guardabassi & Kruse, 2008; CLSI, 
2006a, 2006b). It should be expected that there will be differences between the bacteria 
isolated and their antibacterial sensitivities, between freshwater and saltwater fish, 
between different taxa of fish, and possibly even between different species of fish 
(Mulcahy, 2011). Furthermore, due to the varying activity spectrum of the different 
compounds in some tests, microbial population dynamics may overrule their effects in 
some populations. They may thereby mask effects (Kümmerer, 2008). The discrepancies 
between testing methods may also require further studies (Kum et al., 2008). Differences 
in the measurement of zone sizes by individual scientists also represent a possible source 
of inter-laboratory variation (Nic Gabhainn et al., 2004).  
2.3 The treatment route  
In intensive fish farming, the antibacterials used to treat bacterial infections are 
administrated generally by either water-borne or oral means, or else through injection 
(Shao, 2001; Treves-Brown, 2001; Zounkova et al., 2011). Agents that are intended to treat 
diseases must reach therapeutic levels in target tissues. It is always advisable to perform a 
bioassay of a small number of individuals before treating any fish species without a 
known history of response to the treatment. A bioassay can be performed by placing five 
or six fish in an aquarium that has the treated pond water. The fish should be observed for 
1-2 days before treatment so as to be sure that none have died from the stress of collection. 
Fish should never be left unattended during treatment and, if an adverse response occurs, 
the drug should be immediately removed by transferring the fish to clean water or 
diluting the treatment water. It is necessary to take the presence of these additives into 
account when calculating the active drug quantity required for any treatment (Noga, 2010; 
Rodgers & Furones, 2009). Adequate plans for detoxification and the removal and 
disposal of used drugs must be in place before treatment is begun (e.g., ammonia and 
nitrite levels must be monitored closely during therapy). When hospitalisation is 
completed, the aquarium, the filter, and all other materials in contact with the 
hospitalisation aquarium should be disinfected before re-use. Used drugs must be 
disposed of responsibly. Deteriorated or otherwise uncontrolled water quality poses 
particular challenges to farmed fish and their surroundings. Outputs from these systems 
can further harm local wildlife and the ecosystem (Cottee, 2009). There is no one specific 
drug application method which is better than other; rather, the method of treatment 
should be based on the specific situation encountered. Here, experience is exceptionally 
valuable. A fish health professional or other knowledgeable source should be consulted if 
one is unfamiliar with the disease or treatment proposed (Winton, 2001). Methods for the 
application of antibacterials to fish are resumed in Table 3. 
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Method of 
application 
Comments 
Oral route (on food) Needs palatable components; minimal risk of environmental 
pollution 
Bioencapsulation Needs palatable compounds; minimal risk of environmental 
pollution 
Bath Need for a fairly lengthy exposure to the compound, which must be 
soluble or capable of being adequately dispersed; problem of the 
disposal of spent drug 
Dip Brief immersion in a compound, which must be soluble or capable of 
being adequately dispersed; problem of disposal of the dilute 
compound 
Flush Compound added to a fish holding facility for brief exposure to fish; 
must be soluble or capable of being adequately dispersed; poses a 
problem of environmental pollution 
Injection Feasible for only large and/or valuable fish; usually requires prior 
anaesthesia; slow; negligible risk of environmental pollution 
Topical application Feasible for the treatment of ulcers on valuable/pet fish 
Table 3. Methods for application of antibacterials to fish (Haya et al., 2005). 
2.3.1 Water medication 
The water-borne route is the most common method for administering treatments to fish and 
it has distinct advantages, such as being relatively non-stressful and easy to administer. 
Drugs are added to water for two distinct purposes. The first and most obvious one is so 
that the drug will be absorbed by, and so medicate, the fish; the second is to kill the free-
living and, hence, transmissible stages of parasites (Treves-Brown, 2001). Seawater fish 
drink significant amounts of water and may absorb large amounts of a drug via the 
gastrointestinal tract (Noga, 2010). Application by the water-borne route becomes necessary 
if the fish refuse to eat, and, therefore, would be unlikely to consume any medicated food. 
With these methods, the fish are exposed to solutions/suspensions of the drug for a 
predetermined period. This may be only briefly, i.e., a few seconds duration (a "dip") or for 
many minutes to several hours (a "bath") (Haya et al., 2005). Waterborne antibacterial 
treatments will vary depending upon the animal and its holding conditions. Treating fish by 
applying the drug to the water avoids stressing the fish by handling (Reimschuessel & 
Miller, 2006). However, there are disadvantages. Relative to other treatment routes, dosing 
is less precise (too little or too much). Baths and dips are not as effective as some of the other 
treatment methods – particularly for systemic infections – because of generally poor internal 
absorption of the antibacterial being used. Water-borne treatments are mainly used for 
surface-dwelling (skin and gill) pathogens, including parasites, bacteria and water moulds. 
Certain species, such as scaleless fish are often especially sensitive to water-borne treatments 
(Rodgers & Furones, 2009). Antibacterials which are absorbed from the water include 
chloramines, dihydrostreptomycin, enrofloxacin, erythromycin, flumequine, furpyrinol, 
kanamycin, oxolinic acid, oxytetracycline, nifurpirinol, sulphadimethoxine, sulphadimidine, 
sulpha-monomethoxine, sulphanilamide, sulphapyridine, sulphisomidine and trimethoprim. 
Antibacterials that are absorbed poorly or not at all include chloramphenicol and 
gentamicin (Reimschuessel & Miller, 2006). With bath-type treatments, more antibacterials 
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are required when compared with oral (feed) treatments or injections. Bath treatments are 
also not recommended for recirculation systems or aquarium systems using biological 
filters. The accurate calculation of the volume of water in the tank, pond or cage is also 
required (Rodgers & Furones, 2009). If both short- and long-term exposures are probably 
equally feasible and effective, it is preferable to use a short-duration drug exposure. The 
advantages of this type of treatment lie in reduced waste (and thus reduced expense) and 
less environmental contamination (Reimschuessel & Miller, 2006). Even where absorption is 
known to occur, the technique does have some important disadvantages. In particular, in 
most cases less than 5% of the administered dose will be absorbed by the fish. In this case, 
the technique is wasteful, expensive (at least twenty times the dose required by the fish 
must be provided) and environmentally undesirable (Treves-Brown, 2001). 
2.3.2 Oral medications  
In food fish or ornamental aquaculture, many of the bacterial diseases of fish can be 
successfully treated with medicated feeds, and it is usually the preferred method of 
treatment. However, care must be taken because some of the causes of disease – such as 
stress – can lead to treatment failures or the recrudescence of disease after the completion of 
treatment (Rodgers & Furones, 2009). Fish in ponds are best treated using oral medications. 
However, sick fish may not eat, and withholding food for 12-24 hours may increase the 
acceptance of a medicated feed (Reimschuessel & Miller, 2006). The incorporation of an 
antibacterial in the feed is usually via a powdered premix in conjunction with a binder, such 
as gelatine (up to 5%), fish or vegetable oil (Shao, 2001). The dosage required for treatment 
with a medicated feed depends upon the original level of active ingredient/kg fish body 
weight. The dosage rates used in medicated feeds will vary according to the specific 
antibacterial used, but usually the rate is based on a number of grams per 100 kg of fish per 
day. The exact dosage will also require the number and average weight of the fish to be 
treated, as well as a daily feeding rate and consideration of whether the fish are marine or 
fresh water species. It is also important that treated fish must not be harvested for food use 
until a specified withdrawal period has elapsed (Rodgers & Furones, 2009). One problem for 
the treatment of marine species is that antibacterials have been shown to be less effective in 
seawater, which is related to their reduced bioavailability, e.g., tetracycline has a low 
bioavailability in fish (< 10%) due to binding with sea-water-borne divalent cations such as 
Mg2+ and Ca2+. It is noteworthy that non-bioavailable tetracyclines contaminate the 
environment (Toutain et al., 2010). The bioavailability of some aquaculture drugs in salmon 
held in seawater is shown in Table 4. (Rodgers & Furones, 2009). The dosage can vary 
within certain limits and depending upon the feeding rate. It is usually best to use a feed 
that has enough medication so that feeding at a rate of 1% of body weight per day will give 
the needed dosage (Noga, 2010). Absorption from the intestinal tract may vary between 
species. Saltwater fish will drink and, therefore, drugs may bind cations in the water in their 
intestinal tracts, affecting bioavailability (Reimschuessel & Miller, 2006). For particular 
applications, like the treatment of young larvae and fry, some success has been obtained 
with the bio-encapsulation of drugs in live feeds, especially with artemias. Other innovative 
methods of oral delivery – like microspheres or coated beads – offer the possibility of 
protecting fragile molecules from deterioration in the gastric juices, carrying them up to 
their target sites in the intestine. Though still quite recent, large developments are expected 
from these innovative technologies in the near future (Daniel, 2009). 
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Antibacterial Bioavailability (%)
Oxytetracycline 1
Amoxicillin 2
Sarafloxacin 2
Oxolinic acid 30
Flumequine 45
Sulfadiazine 50
Trimethoprim 96
Florfenicol 97
Table 4. Examples of reduced bioavailability for some aquaculture drugs in seawater 
(Rodgers & Furones, 2009). 
2.3.3 Injection  
The injection of antibacterials can be a more effective treatment for bacterial infections than 
the use of a medicated feed, particularly for advanced infections and as the best way of 
being sure of the given dose (Douet et al., 2009). However, it is usually only practical for 
valuable individual fish, such as brood stock or ornamental fish, rather than for fish in  
large-scale production facilities. Injection quickly leads to high blood and tissue levels of 
antibacterials (Yan & Gilbert, 2004; Haya et al., 2005). Normally, an individual fish will also 
need to be anaesthetised before treatment. Typical injection sites include the intraperitoneal 
(IP) cavity and the intramuscular route (IM) (Rodgers & Furones, 2009; Treves-Brown, 2001). 
Disadvantages include the stress imposed by capturing the fish and, for aquarium fish, the 
need to bring the fish to the clinic for every injection, since the owner is usually unable to 
perform the treatment (Noga, 2010). The IP route is the widely used route for injection. Fish 
should be fasted for 24 hours prior to injection. The landmarks for an IP injection are the 
pelvic fins and the anus. All fish should be at least 35g. Improper injection can lead to 
peritoneal adhesion, ovulation problems, mortality from injection, reduced efficacy, side 
effects (local reactions), reduced carcass quality and therapy failure (Treves-Brown, 2001; 
Noga, 2010). IM injection is best used only on fish more than 13 cm long or else more than 
15g. The best site is the dorsal musculature just lateral to the dorsal fin. Only relatively small 
amounts can be injected (0.05 ml/50 grams of fish). Injections should be done slowly. The 
IM route has the disadvantage of causing damage to carcass quality and has the potential of 
forming sterile abscesses (Noga, 2010). The volume required for the injection of 
antibacterials is based on the weight of fish to be treated, the recommended dosage for the 
antibacterial being used and its supplied concentration (Rodgers & Furones, 2009). This is 
usually expressed as: 
Volume of antibacterial required = recommended dosage (mg/kg) x weight of fish (kg) 
/supplied solution concentration (mg/ml) 
2.3.4 Topical application 
The topical application of drugs to fish is rare. Anaesthesia is an essential preliminary 
procedure. Topical treatments are usually only necessary for more valuable individual fish, 
such as ornamental varieties or brood stock. Ointments containing antibacterials have 
sometimes been used in fish surgeries, applied to the sutures and incision site. Commercial 
antibacterial ointments are most commonly used (Mulcahy, 2011). Open sores or ulcers that 
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are secondarily infected by bacteria or water moulds can be treated. A cotton swab should 
be dipped in a drug solution and then used to gently touch the lesion, allowing the solution 
to soak the lesion via capillary action. Nevertheless, it is possible that ulcers may heal 
themselves with improved water quality and the elimination of parasites (Treves-Brown, 
2001; Haya et al., 2005; Noga, 2010). 
2.3.5 Water treatment 
Disinfection can reduce the risk of disease transmission within aquaculture facilities, and 
from facilities to the environment, by deactivating or destroying pathogens with disinfecting 
agents. Disinfection can be done routinely, but also in response to the outbreak of specific 
diseases (Winton, 2001). In this procedure the drug is applied to all the water in the 
aquarium. It is, therefore, not applicable to antibacterial drugs, as these would inactivate the 
filter (Treves-Brown, 2001). 
2.4 Dosage 
PK and PD data has allowed the design of therapeutic regimens, with the PK/PD variable 
providing the most appropriate surrogate for drug effectiveness being dependent upon 
several factors (Rigos & Troisi, 2005; Martinez & Silley, 2010; Toutain et al., 2010). Within 
some species there may be considerable differences both within and between breeds in PK 
and PD profiles; veterinary pharmacogenetics aims to identify genetic variations 
(polymorphisms) as the origin of differences in the drug response of individuals within a 
given species. These between- and within-species differences in drug response are largely 
explained by variations in drug PK and PD, the magnitude of which varies from drug to 
drug (Toutain et al., 2010). We will not be able to apply the full power of the PK/PD 
approach to either the design of treatment regimens that minimise the development of 
resistance or the setting of clinical breakpoints that provide an empirical definition of 
resistance (Smith et al., 2008). There is a considerable amount of information available on the 
PK of various antibacterials delivered by different routes to different species of fish, but little 
information about the plasma levels of antibacterials that are required to be of benefit for the 
implanted fish or the calculation of the dosage of antibacterial required to obtain a positive 
benefit (Mulcahy, 2011). It is important to remember that it is the host immune system that 
is ultimately responsible for success in combating bacterial disease (Martinez & Silley, 2010). 
If one is unsure about the dose to use, it is usually best to start with the lower recommended 
dose. If the disease does not respond adequately, repeat the treatment with a higher dose. 
For oral medications, dosage varies with feed intake. Fish that are eating less need a higher 
percentage of the drug in their diet, but there are limits on the legally allowable amount as 
well as practical considerations, since some drugs are unpalatable at high doses (e.g., many 
antibacterials) (Noga, 2010; Winton, 2001). Drug dosage regimens also are host-dependent. 
Fish species reared in warm water may absorb, metabolise and excrete drugs at a different 
rate (often faster) than those in cold water. The salinity of the holding water also affects drug 
kinetics. Fish kept in saltwater drink the water while freshwater fish do not. Thus, 
antibacterials in the gastrointestinal tract of fish species held in saltwater may bind cations, 
which can reduce their uptake (Smith et al., 2008; Toutain et al., 2010). This is especially true 
for antibacterials – such as the tetracyclines – that have low bioavailability even in 
freshwater. The half-lives of drugs in fish are highly dependent upon the dosage regimen, 
the route and the temperature. Therefore, these parameters are included in the Phish-Pharm 
Database and should be considered when administering antibacterials to fish. Table 5 shows 
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some drug dosages that have been reported for fish (Reimschuessel et al., 2005). It is 
important to realise that the dosages listed in Table 5 may not have been shown to be safe or 
effective in all fish species. No generalisations are possible. Successful therapy often 
depends on maintaining adequate blood levels over a course of seven to ten days. 
Temperature is a very important factor in deciding on the dose and treatment intervals 
(Toutain et al., 2010). 
 
Drug Species t1/2 (hr) Dosage Routeb °C 
Amoxicillin Atlantic salmon 120 12.5 mg/kg sda IM 13 
 Atlantic salmon, sea bream 14-72 40-80 mg/kg sd IV/PO 16-22 
Chloramphenicol Carp 48-72 40 mg/kg sd IP 9 
Ciprofloxacin 
Carp, rainbow trout, African 
catfish
11-15 15 mg/kg sd IM/IV 12-25 
Difloxacin Atlantic salmon 16 10 mg/kg sd PO 11 
Enrofloxacin 
Atlantic salmon, red pacu, 
rainbow trout, sea bass, sea 
bream
24-105 5-10 mg/kg sd
IM/IV/P
O 
10-26 
Erythromycin Chinook salmon 120 0.1 g/kg 21 d PO 10 
Florfenicol Atlantic salmon 12-30 10 mg/kg sd IV/PO 10-11 
 Cod 39-43 10 mg/kg sd IV/PO 8 
Flumequine Eel 255 9 mg/kg sd IM 23 
 
Atlantic halibut, brown trout, 
corkwing wrasse, Atlantic 
halibut,
21-96 5-25 mg/kg sd IP/IV/PO 5-25 
 
Atlantic salmon, cod, 
goldsinny wrasse, sea bass, 
sea bream, turbot
    
 Eel 208-314 10 mg/kg sd IV/PO 23 
 Rainbow trout 285-736 5 mg/kg sd IV/PO 13 vs 3 
Furazolidone Channel catfish 1-24 1 mg/kg sd IV/PO 24 
Gentamicin 
Channel catfish, brown shark, 
goldfish
12-54 1-3.5 mg/kg sd IC/IM 20-25 
 Toadfish 602 3.5 mg/kg sd IM 19 
Miloxacin Eel 35 30-60 mg/kg sd IV/PO 27 
Nalidixic acid Rainbow trout, amago salmon 21-46 5-40 mg/kg sd IV/PO 14-15 
Nifurstyrenate Yellowtail 2 100 mg/kg sd PO 23 
Ormetoprim 
Atlantic salmon, channel 
catfish, rainbow trout, hybrid 
striped bass
4-25 4-50 mg/kg sd IV/PO 10-28 
Oxolinic acid 
Atlantic salmon, corkwing 
wrasse, channel catfish, cod, 
rainbow trout, red sea bream, 
sea bass
15-87 4-20 mg/kg sd IP/IV 8-24 
 
Atlantic salmon, cod, rainbow
trout
82-146 25-75 mg/kg sd PO 5-8 
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Atlantic salmon, gilthead 
sea bream, rainbow trout, 
sharpsnout, sea bream, turbot
13-48 
10-40 mg/kg 
up to 10d 
PO 9-19 
Oxytetracycline 
African catfish, carp, rainbow 
trout, red pacu, sockeye 
salmon
63-95 5-60 mg/kg sd IM 12-25 
 
African catfish, Atlantic 
salmon, ayu, carp, Chinook 
salmon, eel, rainbow trout, 
red pacu, sea bass, sea bream, 
sharpsnout, sea bream
6-167 5-60 mg/kg sd IV 8-25 
 Arctic charr 266-327 10-20 mg/kg sd IV 6 
 
Atlantic salmon, ayu, black
sea bream, carp, channel 
catfish, eel, perch, rainbow 
trout, sea bass, sea bream, 
hybrid striped bass, summer, 
flounder, walleye
43-268
10-100 mg/kg 
up to 10d 
PO 7-27 
 
Arctic charr, sockeye salmon, 
Chinook salmon 
428-578 10-100 mg/kg sd PO 6-11 
Piromidic acid Eel, goldfish 24 5 mg/kg sd PO 26 
Sarafloxacin Atlantic salmon, cod 12-45 10-15 mg/kg sd IV/PO 8-24 
Streptozotocin Toadfish 24 50 uCi IV  
Sulphachlor-
pyridazine 
Channel catfish 4-5 60 mg/kg sd IC/PO 22 
Sulfadiazine 
Atlantic salmon, carp, 
rainbow trout 
26-96 25-200 mg/kg sd IV/PO 8-24 
Sulfadimethoxine
Atlantic salmon, channel 
catfish, rainbow trout, hybrid 
striped bass 
1-48 25-200 mg/kg sd IV/PO 10-20 
Sulphadimidine Carp, rainbow trout 18-57 100-200 mg/kg sd IV/PO 10-20 
Sulphametho-
xypyridazine 
Rainbow trout 72 200 mg/kg sd PO 13 
Sulphamono-
methoxine 
Rainbow trout, yellowtail 5-33 100-400 mg/kg sd IV/PO 15-22 
Sulphanilamide Rainbow trout 36 200 mg/kg sd PO 13 
Sulfathiazole Rainbow trout 60 200 mg/kg sd PO 13 
Thiamphenicol Sea bass 21 30 mg/kg 5d PO 19 
Tobramycin Brown shark 48 1-2.5 sd IM 25 
Trimethoprim 
Atlantic salmon, carp, 
rainbow trout 
21-50 1-100 mg/kg sd IV/PO 8-24 
Vetoquinol Cod 79 25 mg/kg sd PO 8 
 Atlantic salmon 16 40 mg/kg sd PO 10 
asd: single dose. bAbbreviations, IM: intra muscular, IV: intra venous, PO: per os (oral), IP: intra 
peritoneal, IC: intra coelom, uCi: a unit of radioactivity (Curie= 3,7x1010 disintegration per second). 
Table 5. Half-lives and dosages of antibacterials in fish (Reimschuessel et al., 2005). 
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2.5 Drug metabolism in fish 
Liver is the primary organ for the detoxification of drugs in fish. Similarities exist in the 
metabolism of drugs by fish and mammals. The metabolism of aquaculture antibacterials 
by the cytochrome P450 system could affect their activation, tissue distribution and 
elimination rates, and determine the persistence of residues as well as the length of the 
withdrawal period before the fish can be used for human consumption (Moutou, 1998). 
The elimination rate of antibacterials from fish tissues varies greatly with the temperature. 
The temperature dependency of drug PK is an important consideration for drug residues. 
The elimination half-life of antibacterial drugs increases significantly as the temperature 
decreases. Ideally, the drug dose should be adjusted according to the water temperature, 
but in clinical practise the dose is normally fixed (Toutain et al., 2010). However, 
unmetabolised oxytetracycline can be passed unabsorbed through the body of treated 
sparids and then excreted via the faeces into the local marine environment (Rigos & 
Troisi, 2005; Rigos et al., 2004).  
2.6 Duration of antibacterial treatment 
It is universally recognised that a drug must be present in a sufficient concentration for an 
adequate length of time at the site of the infection, although the variables affecting the 
length of treatment have not yet been fully defined (Walker & Giguére, 2008). The 
responses of different types of infections to antibacterial drugs vary, and clinical 
experience with many infections is important in assessing the response to the treatment. 
For serious acute infections, treatment should last at least 7 to 10 days. If no response is 
seen by that time, both the diagnosis and treatment should be reconsidered (Walker & 
Giguére, 2008). It is important to remember that it is the host immune system that is 
ultimately responsible for any success in combating bacterial diseases (Martinez & Silley, 
2010). 
2.7 Failure of antibacterial therapy  
Treatment failure has many causes. The selected antibacterial may be inappropriate because 
of misdiagnosis, poor drug diffusion at the site of the infection, inactivity of a given drug at 
the site of infection, failure to identify the aetiological agent including inaccurate results of 
laboratory tests, resistance of pathogens, intra-cellular location of bacteria, metabolic state of 
the pathogen, or errors in sampling. Other factors that may contribute are inadequate 
dosage or the use of drugs with low bioavailability. When failure occurs, diagnose must be 
reassessed and proper samples collected for laboratory analysis. Patient factors such as the 
persistence of foreign bodies, neoplasia, and impairment of host defences are important to 
consider. It is important also to ensure that persons medicating their own animals comply 
with dosing instructions (Walker & Giguére, 2008; Winton, 2001; Treves - Brown, 2001; 
Noga, 2010).  
3. Treatment options in various aquaculture systems 
Another important factor influencing treatment is the type of culture system. The four major 
types of culture system are aquaria, ponds, cages and flow-through systems (Noga, 2010). 
The main factors that may influence a treatment’s success are given in Table 6. 
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Aquaria Ponds Cages Raceways 
The most highly 
controllable culture 
systems for 
maintaining 
temperature, 
biological filtration 
and oxygen.  
Amenable to 
various waterborne 
treatments. Ease of 
manipulability. 
 
Influenced by 
natural factors such 
as light, 
temperature and 
rainfall. 
Natural biological 
cycles are less 
controllable. 
Interventional 
strategies are more 
limited compared 
with aquaria. 
 
Susceptible to the 
vagaries of natural 
environmental 
changes.  
Water-borne 
treatments are 
possible in such 
systems, but are 
much more difficult. 
The fish that need 
to be treated in such 
systems must have 
their cage enclosed. 
Alternatively, the 
fish must be treated 
in a closed system 
(e.g., a bath 
treatment) or the 
medications must 
be delivered orally. 
Raceways and other 
flow-through 
systems are the 
least manipulable 
systems by virtue of 
the constant and 
rapid water 
turnover. 
Similar adverse 
environmental 
consequences can 
follow such 
treatments.  
Flow-through 
systems are even 
more limited than 
cages in the ability 
to use water-borne 
treatments. 
Table 6. Major types of culture systems influencing the diseases’ treatment (Table 
established from (Noga, 2010)). 
4. Legal use of antibacterials 
A number of international and regional codes of practice, agreements and technical 
guidelines exist for aquatic animals (Subasinghe, 2009). The drugs available for use and their 
treatment protocols are tightly regulated. The consumers of fish – and particularly in the 
world’s richer economies – are increasingly demanding that retailers guarantee that the fish 
which they offer are not only of a high quality and safe to eat, but also that they derives 
from fisheries that are sustainable (FAO, 2011). As health threats have appeared, 
management practices have evolved and fish husbandry has greatly improved over the past 
20 years, resulting in a reduction in the use of some chemicals, and particularly the use of 
antibacterials in most jurisdictions (Burridge et al., 2010). The banning of any antibacterial 
usage in animals based upon the “precautionary principle” in the absence of a full 
quantitative risk assessment is likely to be wasted at best, and even harmful at worst, both to 
animal and human health (Phillips et al., 2004). The antibacterials used in veterinary 
medicine are only prescribed by veterinarians in the European Union (EU). The prescription 
scheme could be discussed and improved, and non-approved and even banned 
antibacterials are purchased "over-the-counter" (without the need for a prescription) or their 
use is undeclared in fish feed formulations. The use of specifically banned antibacterials in 
aquaculture is a violation of regulations (Lupin, 2009). The user safety data included on 
labelling and packaging inserts should provide sufficient information for such occupational 
safety assessments to be made (Alderman & Hastings, 2009). Before approval, drugs are 
assessed for the definition of their maximum residue limits (MRLs) (Table 7), and their 
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environmental impact and efficacy (Sanders, 2005). MRLs are generated by a number of 
bodies, such as the EU, and more globally within the framework of the FAO/WHO Codex 
Alimentarius Commission, which is advised scientifically by the JECFA (Joint FAO/WHO 
Expert Committee on Food Additives). The use of antibacterial agents in food animal 
species, including fish, is controlled by regulations, particularly in Europe and the USA.  
 
Antibacterial Species* Tissue** MRL Comments 
Amoxicillin  All FPS Muscle 50 pg/kg  
Ampicillin  All FPS Muscle 50 pg/kg  
Benzylpenicillin  All FPS Muscle 50 pg/kg  
Chlortetracycline  All FPS Muscle 100 pg/kg  
Cloxacillin  All FPS Muscle 300 pg/kg  
Colistine  All FPS Muscle 150 pg/kg  
Danofloxacin  All FPS Muscle 100 pg/kg  
Dicloxacillin  All FPS Muscle 300 pg/kg  
Difloxacin  All FPS Muscle 300 pg/kg  
Enrofloxacin  All FPS Muscle 100 pg/kg Enro.+ciprofloxacin 
Erythromycin  All FPS Muscle 200 pg/kg Erythromycin A 
Florfenicol (Fish)  Fish Muscle+skin 1000 pg/kg  
Flumequine  Fish Muscle+skin 600 pg/kg  
Lincomycin All FPS Muscle 100 pg/kg  
Neomycin 
(Incl. Framycetin)  
All FPS Muscle 500 pg/kg Neomycin B 
Oxacillin  All FPS Muscle 300 pg/kg  
Oxolinic Acid Fish Muscle+skin 100 pg/kg  
Oxytetracycline  All FPS Muscle 100 pg/kg  
Paromomycin  All FPS Muscle 500 pg/kg  
Sarafloxacin  
(Fish & Poultry) 
Salmonids Muscle+skin 30 pg/kg  
Spectinomycin  All FPS Muscle 300 pg/kg  
Sulphonamides (All)  All FPS Muscle 100 pg/kg  
Tetracycline  All FPS Muscle 100 pg/kg  
Thiamphenicol  All FPS Muscle 50 pg/kg  
Tilmicosine  All FPS Muscle 50 pg/kg  
Trimethoprim  All FPS Muscle 50 pg/kg  
Tylosin  All FPS Muscle 100 pg/kg  
*All FPS: all food producing species (with some exclusions and depending on each compound). 
**For all fish MRLs, the target tissues "muscle" or "muscle and skin" shall be understood as "muscle and 
skin in natural proportions." 
Table 7. Main antibacterial compounds having fixed MRLs (Modified from (Daniel, 2009)). 
The approval process is very costly and time consuming, and the sales potential for the 
aquaculture market in global terms is limited, which in some cases has meant a certain 
lack of interest on the part of pharmaceutical companies for developing new antibacterials 
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and registering them (Alderman & Hastings, 2009; Rodgers & Furones, 2009). In the USA, 
the regulatory authority for the approval of Veterinary Medicinal Products (VMPs) is the 
FDA (FDA, 2009, 2011). The body that is responsible for the authorization procedure in 
the EU is the European Medicines Agency (EMEA) and the European Commission, or else 
the national competent authorities in the EU Member States (depending on the procedure 
chosen for the marketing authorisation application). The EMEA's Committee for 
Medicinal Products for Veterinary Use (CVMP) carries out the scientific evaluation 
(Sanders, 2005; Prescott, 2008; Valois et al., 2008; Alderman, 2009). Compared to 
agricultural use and medicinal use, the market for aquaculture antibacterials is fairly 
small and the approval process can be expensive. The availability of antibacterial agents 
for aquacultural use is affected by the setting of MRLs. However, these withdrawal times 
are based on studies that are mainly performed on fish held in temperate freshwater. The 
excretion of a drug by a fish can vary greatly with its environmental conditions, and 
especially the temperature (Daniel, 2009; Noga, 2010). Because of the variability of drug 
excretion, especially with temperature, a rule of thumb called “degree days” has been 
advocated for estimating the required withdrawal time. If the data does not indicate a 
temperature effect on depletion, then a day-based withdrawal can be accepted (Alderman 
& Hastings, 2009). 
5. Problems associated with antibacterial use in aquaculture 
Consumers demand guarantees that their food has been produced, handled and sold in a 
way that is not dangerous to their health, and which respects the environment and 
addresses various other ethical and social concerns (FAO, 2011). Even if the occurrence, 
effects and fate of antibacterials have been considered from the perspective of scientific 
interest, little is still known about the actual risk to both humans and the environment 
(Kemper, 2008). However, medicines legislation requires that user-safety be assessed in the 
safety package and that the product label must include advice and warnings to the user, 
giving guidance for safe use. Any hazards associated with feed medication – whether in 
feed mills or on farms – must be considered, as must any hazards to the final user (the fish 
farm staff) (Alderman & Hastings, 2009). The majority of fishers and aquaculturists are in 
developing countries, and mainly in Asia which has experienced the largest increases over 
recent decades, reflecting the rapid expansion of aquacultural activities (Sapkota et al., 2008; 
FAO, 2011; Smith et al., 2008). Fish diseases are generally coupled with cultured fish and 
viewed as a result of aquaculture (Bergh, 2007). As a consequence, it is probable that the 
majority of antibacterial use in world aquaculture is not associated with any classification of 
the target bacterium or of its susceptibility to the range of available antibacterials (Smith et 
al., 2008). There is also a need for assurance that the usage will not harm animals or humans 
(Phillips et al., 2004). With an increase in consumers’ recognition of the health benefits 
associated with seafood consumption, the volume of fisheries and aquaculture products 
consumed is expected to rise (Storey, 2005). There is little doubt that aquaculture production 
will continue to grow (Asche et al., 2008). The world food supply will probably have to 
double in quantity and increase in quality over the next 30–50 years as populations and 
incomes rise. The demand for fish as food will probably double and could even more than 
double (Pullin et al., 2007). Consequently, an increase in the number of problems associated 
with aquaculture production may be expected.  
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5.1 Toxicity to the host 
Antibacterials that are sufficiently non-toxic to the host are used as chemotherapeutic agents 
in the treatment of the infectious diseases of humans, animals and plants. Direct host 
toxicity is the most important factor limiting drug dosage. Tolerance studies must be carried 
out to determine the safety of the product to the target fish species (Alderman & Hastings, 
2009). Also, it is important for the clinician to report adverse drug events to legal authorities. 
Antibacterial agents can have a wide variety of damaging effects on the host, including: (1) 
direct host toxicity; (2) adverse interactions with other drugs; (3) interference with the 
protective effect of normal host microflora or the disturbance of the metabolic function of 
microbial flora in the digestive tract of herbivores; (4) the selection or promotion of 
antibacterial resistance; (5) tissue necrosis at injection sites; (6) drug residues in animal 
products that are intended for human consumption; (7) impairment of the host's immune or 
defence mechanisms; and (8) damage to foetal or neonatal tissues (Guardabassi & Kruse, 
2008; Mulcahy, 2011). Nonetheless, the most used aquaculture antibacterial agent 
oxytetracycline may have genotoxic and ecotoxic effects in aquatic ecosystems (Zounkova et 
al., 2011). The selective toxicity of antibacterials is variable. Some agents, such as beta-
lactams, are generally considered to be safe, whereas others, such as the aminoglycosides, 
are potentially toxic (Guardabassi & Kruse, 2008).  
5.2 Resistance of aquatic bacteria 
The capacity of bacteria to adapt to changes in their environment and thus survive is called 
resistance. Drug choices for the treatment of common infectious diseases are becoming 
increasingly limited and expensive and, in some cases, unavailable due to the emergence of 
drug resistance in bacteria (FAO, 2005). In general, aquatic bacteria are not different from 
other bacteria in their responses to exposure to antibacterial agents, and they are capable of 
transferring antibacterial resistance genes to other bacteria (Heuer et al., 2009). The WHO 
has long recognised that antibacterial use in food animals – which seems to outweigh 
antibacterial use for human therapy in many countries – contributes importantly to the 
public health problem of antibacterial resistance (WHO, 2011). The resistance of pathogenic 
bacteria to antibacterials is a growing problem in human and veterinary medicine, and 
antibacterial use in fish – especially in aquaculture – is an area of increasing concern over 
health risks (Kemper, 2008; Mulcahy, 2011). The fact that some of the bacteria that cause 
infections in fish belong to the same genera as the bacteria causing infections in humans is 
likely to increase the probability of the spread of antibacterial resistance from aquaculture 
to humans (Heuer et al., 2009). The continued use of subtherapeutic levels of 
antibacterials to prevent disease increases the likelihood of establishing populations of 
multiply resistant strains of pathogenic bacteria. These may ultimately result in outbreaks 
of disease which cannot be controlled by antibacterial therapy (Mulcahy, 2011; Roberts, 
2004). Also, the selection and use of inappropriate antibacterials, and the use of 
insufficient dosages, incorrect routes of application, incorrect dosing frequencies and 
administering antibacterials for an insufficient time period, are ways to select for 
antibacterial-resistant bacteria (Mulcahy, 2011). The excessive use of antibacterials in fish 
aquaculture is increasing the resistance in bacteria that can infect both humans and 
animals (Burridge et al., 2010; Kümmerer, 2010; Defoirdt et al., 2011). It is not only the 
direct therapeutic use of antibacterials, but also their indirect contact with them which 
might enhance the resistance of bacteria: not taking into account the bacteria's origins, 
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resistance genes have been isolated from human pathogens, bacteria of animal origin and 
even environmental bacteria (Kemper, 2008; Martinez & Silley, 2010; Martinez, 2009). The 
consequences of increasing resistance in bacteria and the diminishing impact of 
therapeutic drugs reach far beyond the geographic origins of antibacterial compounds 
and are, therefore, of global concern (Kemper, 2008). 
Antibacterials exhibit different activity spectra and mechanisms of action. It has been 
recognised for some time that susceptibility to antibacterials varies markedly both between 
different groups of organisms and within these groups (Kümmerer, 2008). A large variety of 
antibacterial resistance mechanisms have been identified in bacteria and several different 
mechanisms may be responsible for resistance to a single antibacterial agent in a given 
bacterial species. Antibacterial resistance mechanisms can be classified into four major 
categories (shown in Table 3.1 by the asterisk): (1) the antibacterial agent can be prevented 
from reaching its target by reducing its penetration into the bacterial cell; (2) general or 
specific efflux pumps may expel antibacterial agents from the cell; (3) the antibacterial agent 
can be deactivated by modification or degradation, either before or after penetrating the cell; 
or (4) the antibacterial target may be modified so that the antibacterial cannot act on it 
anymore, or else the microorganism's acquisition or activation of an alternate pathway may 
render the target dispensable (see Table 8) (Boerlin & White, 2008; Nikaido, 2009). 
Drug resistance may be natural or acquired (Roberts, 2004; Douet et al., 2009). Some 
organisms have always been resistant to a particular agent by the nature of their physiology 
or biochemistry (i.e., inherent or intrinsic resistance); others have acquired resistance as a 
result of the application of antibacterials by humans (i.e., acquired resistance) (Kümmerer, 
2008). Resistance to antibacterials may be acquired by the mutation of a chromosomal gene 
which modifies the structure of the ribosomal target or by the infection of the cell with a 
resistant R-factor plasmid. Plasmids are extrachromosomal circular DNA molecules capable 
of autonomous replication (Alderman & Hastings, 1998; Boerlin & White, 2008; Defoirdt et 
al., 2011). Once they are integrated in successful gene-transmission elements, antibacterial 
resistance genes can persist and spread even in the absence of antibacterials (Martinez, 
2009). Multidrug resistance in bacteria occurs with the accumulation – on resistant R 
plasmids or transposons – of genes, with each coding for resistance to a specific agent, 
and/or by the action of multidrug efflux pumps, each of which can pump out more than 
one drug-type (Nikaido, 2009). The demonstration of R-factor transfer to fish pathogens was 
first shown with certain strains of Aeromonas salmonidae. Also, transferable R-factor plasmids 
in drug-resistant strains were shown with Aeromonas hydrophila, Vibrio anguillarum, marine 
Vibrio sp., Edwardsiella tarda and Patteurella piscicida (Alderman & Hastings, 1998). 
Tetracycline-resistance genes are found even in small farms which rarely use antibacterials. 
The copy numbers of tetA, tetC, tetH, and tetM genes (tetR reported by Seyfried et al., 
(2010)) remain elevated at farms over the surveillance period of four years in the absence of 
any selection pressure from tetracycline or even other antibacterials (Schmitt & Römbke, 
2008; Tamminen et al., 2010). The continued introduction of tetracycline-resistant organisms 
from the hatchery to the stream, even after a significant time period had elapsed since the 
use of antibacterials, indicates the presence of reservoirs of organisms or unknown sources 
of resistance (Stachowiak et al., 2010) as well as other aquatic bacteria, and also illustrates 
that these bacteria can act as reservoirs of resistance genes that can be further disseminated. 
Ultimately, resistance genes in the aquatic environment may reach human pathogens and 
thereby add to the burden of antibacterial resistance in human medicine (Heuer et al., 2009).  
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Antibacterial agent Resistance mechanism * Examples of genetic 
determinant 
Tetracycline Inducible efflux of tetracycline in E. coli and 
other Enterobacteriaceae 
2 tetA, tetB, tetC 
 Ribosomal protection in Gram-positive  
bacteria 
4 tetO, tetM 
Chloramphenicol Efflux in Enterobacteriaceae 2 cmlA, floR 
 Acetylation in Enterobacteriaceae 3 catA 
ß-lactams ß-lactamases in Enterobacteriaceae,  
Staphylococcus aureus 
3 blaTEM, 
blaSHV,blaCMY-2,blaZ 
Oxacillin, methicillin Alternate penicillin-binding proteins in 
Staphylococcus aureus 
4 mecA 
Imipenem Decreased porin formation in Enterobacter 
aerogenes and Klebsiella spp. 
1 Mutations 
Aminoglycosides Phosphorylation, adenylation, and 
acetylation of aminoglycosides in Gram-
negative and -positive bacteria 
3 Numerous genes 
with a broad variety 
of specificities 
Streptomycin Modification of ribosomal proteins or of 16s 
rRNA in Mycobacterium spp. 
4 Mutations 
Macrolides, 
lincosamides, 
streptogramins 
Methylation of ribosomal RNA in Gram-
positive organisms 
4 ermA, ermB, ermC 
Macrolides, 
streptogramins 
Staphylococcus spp. 2 vga(A), msr(A) 
Fluoroquinolones DNA topoisomerases with low affinity to 
quinolones 
4 Mutations in gyrA, 
gyrB, parC, parE 
Sulphonamides Bypass of blocked pathways through 
additional resistant dihydropteroate  
synthase in Gram-negative bacteria 
4 Sul1, sul2, sul3 
Trimethoprim Bypass of blocked pathways through 
additional resistant dihydrofolate reductase
4 Diverse dfr genes 
Note: This is by no means a comprehensive list of all the resistance mechanisms for each category of 
antibacterials listed. *: Numbers 1, 2, 3 and 4 refer to mechanisms listed in the text. 
Table 8. Examples of resistance mechanisms (Boerlin & White, 2008). 
Aquaculture is thought to stimulate the spread and stability of antibacterial resistance in the 
environment (Sapkota et al., 2008). Commercial fish production facilities could be a source 
of antibacterial-resistant microorganisms to receiving waters at times when there is no active 
use of antibacterials as a result of cross-resistance induced by biocides (Stachowiak et al., 
2010). It has been shown that antibacterial-resistant bacteria are more likely to occur in the 
water and sediment associated with aquaculture. Already, in several areas of the world, this 
is beginning to take place. The comparison of predicted antibacterial concentrations to 
published minimum inhibitory concentrations suggests that antibacterials in wastewater – 
but probably not antifungals – may select for low-level antibacterial resistance (Kostich & 
Lazorchak, 2008). Also, the presence of R-factor-infected populations of bacteria in 
aquaculture systems may lead to the transfer of antibacterial resistance to other micro-
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organisms, including potential human pathogens (Roberts, 2004; Cabello, 2006). Both the 
percentage and level of bacterial resistance to drugs was higher when drugs were 
administered as medicated feed. In addition, the duration of the resistance was longer when 
medicated feed was the mode of administration. The presence of feed residue in the aquatic 
system would have an important effect for the generation and maintenance of the drug 
resistance of bacteria in sediment (Yu et al., 2009). 
These results call for the development of better management strategies for fish farming so as 
to prevent the emergence of resistant gene pools in the sediments of aquaculture facilities, 
and to promote the disappearance of established resistant gene pools (Tamminen et al., 
2010). Principles for the prudent use of antibacterials should be developed and awareness of 
the problem of antibacterial resistance should be raised by informing the public (FAO, 2005). 
The most effective and direct approach is thought to be the reasonable use of antibacterials 
in health protection and agriculture production (Zhang et al., 2009). Without a doubt, a 
promising approach for proper risk-assessment and management would be the reduction of 
the emission of antibacterials into the environment, whether of human or veterinary medical 
origin. In either case, it may not be appropriate to assume that terminating the use of 
antibacterials will lead to a rapid decrease in resistant organisms (Stachowiak et al., 2010). 
The appropriate use of antibacterials in livestock production will preserve the long-term 
efficacy of existing antibacterials, support animal health and welfare, and limit the risk 
factors of transferring antibacterial resistance to animals and humans (Kemper, 2008). 
Whatever is done, the competent surveillance of disease and antibacterial resistance, as well 
as the repeated refinement of risk analyses, are a necessity if we are to concentrate our 
efforts to limit the effects of antibacterial resistance on what is shown to work in practice 
(Phillips et al., 2004; Sanders, 2005). In general, the emergence of resistance to antibacterials 
is a highly complex process, which is not yet fully understood with respect to the 
significance of the interaction of bacterial populations and antibacterials, even in a medicinal 
environment (Kümmerer, 2010). In the EU, the EMA works for the development of a 
harmonised approach to the surveillance of antibacterial usage in animals and the collection 
of data from EU Member States (WHO, 2011). Also, research projects should be encouraged 
which aim at the better understanding of the mechanisms of the emergence and spread of 
resistance within a species, and from animal to human and the environment (FAO, 2005). 
5.3 Aquatic food residues 
The case of the residues of antibacterial substances in fish and fish products represents, in 
practice, a complex problem for society and regulators, and particularly in developing 
countries where regulations and the possibilities for enforcing them are scarce (Cabello, 
2006; Lupin, 2009). In addition to selecting for antibacterial resistance, the heavy 
prophylactic and therapeutic use of antibacterials in aquaculture environments can lead to 
elevated antibacterial residues in ponds, marine sediments, aquaculture products, wild fish 
and other natural aquatic environments that are impacted by aquaculture facilities (Sapkota 
et al., 2008). Also, the use of large amounts of antibacterials that have to be mixed with fish 
food creates problems for industrial health and increases the opportunities for the presence 
of residual antibacterials in fish meat and fish products (Cabello, 2006). Withdrawal times 
are recommended, and in many countries they are legally enforced for some drugs, and 
especially antibacterials. The Food Animal Drug Avoidance Databank (FARAD) assists 
veterinarians in estimating residue-depletion times for antibacterial agents that are 
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administered at doses in excess of label recommendations (Walker & Giguére, 2008). A good 
rule of thumb for the withdrawal time is 500 degree days. Thus, if the mean daily water 
temperature after treatment is 10°C, the withdrawal period should be at least 50 days (10 x 
50 = 500), while at 25° C, the withdrawal period would be 20 days (Noga, 2010). Obviously, 
this can only be a rough estimate of the elimination-rate because temperatures fluctuate 
diurnally and from day-to-day and other factors besides temperature affect elimination-
rates. Note also that 500 degree days might not be sufficient in some cases (Treves - Brown, 
2001). Therefore, the accurate and sensitive determination of antibacterial residues is now a 
necessity. In order to protect human health, the EU and other regulatory authorities 
worldwide have established MRLs for antibacterial residues in animal products entering the 
human food chain (Cañada-Cañada & Pena, 2009; Lupin, 2009). Research projects should be 
promoted on pharmacology and the PK of antibacterials in aquatic species in order to 
provide a more exact approach to establishing MRLs’ values (Table 7) (FAO, 2005). 
5.4 Environmental impact of antibacterial use in aquaculture 
Aquaculture is so integrally linked to the surrounding environment that if sustainable 
practices are not employed, the degradation of the surrounding environment will 
ultimately lead to the degradation of the industry itself (Bergh, 2007). The wellbeing of the 
environment – in cases of disease and treatment – is related to two aspects of biota 
conservation; the transmission of microbial pathogens to wild populations and the 
pollution from chemotherapeutics (Grigorakis, 2010). The extensive use of veterinary 
pharmaceuticals is supposed to represent a daunting public health risk, resulting not only 
in the emergence and spread of resistant bacteria, but also in other human, animal and 
environmental impairments (Kemper, 2008). The input of resistant bacteria into the 
environment from different sources seems to be the most important basis of resistance in 
the environment. The possible impact of resistant bacteria on the environment is not yet 
known and the health risks of active pharmaceutical ingredients remain poorly 
understood (Kümmerer, 2010). The physicochemical fate and environmental 
concentrations of antibacterials in soil has been the subject of a number of recent studies. 
During recent years, significant attention has been paid to the occurrence of drugs in the 
environment. Several classes of antibacterials have been detected in field soils, and their 
sorption behaviour and degradation have been studied to a large extent (Schmitt & 
Römbke, 2008; Zounkova et al., 2011). In general, farmed fish is as safe and nutritious as 
wild-caught species, but there are public health hazards associated with ignorance, abuse 
and the neglect of aquaculture technology. Numerous small fish ponds increase the 
shoreline of ponds, causing higher densities of mosquito larvae and cercaria, which can 
increase the incidence and prevalence of lymphatic filariasis and schistosomiasis 
(Lessenger, 2006). Fish production can generate considerable amounts of dissolved 
effluents, which potentially affect water quality in the vicinity of the farms and, due to 
rapid dilution, also at larger scales (km-scale) (Costanzo et al., 2005; Holmer et al., 2008). 
High antibacterial load in sediments and in concentrations potent enough to inhibit the 
growth of bacteria have been reported for aquaculture (Kümmerer, 2008). 
Tetracycline has a low bioavailability in fish (< 10%), due to binding with sea-water-borne 
divalent cations such as Mg+2 and Ca+2. It is noteworthy that non-bioavailable 
tetracyclines contaminate the environment (Rigos & Troisi, 2005). However, it has been 
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shown that residues of oxytetracycline in marine sediments were very stable over a period 
of months (Toutain et al., 2010). Often, the existing data used to assess the environmental 
effects of antibacterials is not adequate for the establishment of how long bacteria 
maintain antibacterial resistance in the absence of continued selective pressure for that 
resistance (Kümmerer, 2008). Also, in order to minimise the possible risks of antibacterials 
in dust, the use of antibacterials in livestock farming should be strictly reduced to 
therapeutic use (Hamscher & Hartung, 2008). In one study (Wei et al., 2011) conducted in 
China (Jiangsu Province) – the biggest aquaculture producer (FAO, 2011) – contamination 
with antibacterials indicated that ten veterinary antibacterials around farms were found in 
animal wastewaters, eight antibacterials were detected in pond waters, and animal farm-
effluents and river water samples were contaminated by nine antibacterials. The most 
frequently detected antibacterials were sulphamethazine (75%), oxytetracycline (64%), 
tetracycline (60%), sulfadiazine (55%) and sulphamethoxazole (51%). This research has 
demonstrated that animal wastewater is a major source of pollution of veterinary 
antibacterials. By applying the animal wastewater to agricultural soils, the antibacterials 
might contaminate the soils and surrounding water systems, thus posing a serious threat 
to humans and wildlife (Figure 2) (Boxall et al., 2004; Wei et al., 2011). Antibacterials may 
be detected in effluent entering receiving waters and be detectable 500m from the source 
(Costanzo et al., 2005). There is very little information about the chronic toxicity or the 
bioaccumulation potential of pharmaceuticals in biota and food chains (Christen et al., 
2010). Not much is known about the occurrence, fate and activity of metabolites 
(Kümmerer, 2010). Another study showed that more than 30 antibacterial substances have 
been found in sewage influent and effluent samples, in surface waters and even in ground 
and drinking water (Kemper, 2008). At the same time, with antibacterials, disinfectants, 
and heavy metals being released into water, they might exert selective activities as well as 
ecological damage in water communities, resulting in antibacterial resistance (Baquero et 
al., 2008). For example, the exposure of eels to pollution during their development is 
inducing changes on the biomarkers involved in physiological functions that are 
determinants for the survival and performance of the eels, namely biotransformation 
enzymes and antioxidative stress defences, and these alterations may have negative 
effects on sexual development. In addition, the mechanisms used to face chemical stress 
need energy which is probably allocated from other functions, such as tissue repair, 
growth and weight increase, and which are determinants for a successful migration into 
the reproduction area (Gravato et al., 2008). 
Ideally, aquaculture operations would be planned with background knowledge of the 
ecosystems in which the facilities will operate as well as knowledge of the potential 
environmental, social, and economic effects (both positive and negative) that could be 
incurred, and the cost:benefit ratio associated with operating, given knowledge of that 
background (Bergh, 2007). Environmental observations and models can then be combined 
with effective aquaculture husbandry practices so as to manage environmental risks from all 
sources (Hargrave et al., 2005). Hopefully, research on aquaculture-environment interactions 
has progressed remarkably during recent years, particularly in the framework of EU-funded 
projects, which have provided useful information for the understanding of various 
ecosystem processes affected by the presence and operation of fish farms (Holmer et al., 
2008). 
www.intechopen.com
 
Antibacterial Drugs in Fish Farms: Application and Its Effects 
 
241 
 
Fig. 2. Routes of pharmaceuticals entering the environment (Boxall et al., 2004). 
6. Antibacterial usage suggestions in aquaculture 
When it is apparent that a treatment is necessary, the following check-lists may be useful 
(Winton, 2001): 
Before treating: 
1. Accurately determine the water-volume, flow-rate, and temperature. 
2. Accurately determine the number and total weight of fish in the rearing unit. 
3. Confirm the identity, expiration date, and active ingredient concentration of the 
regulated product to be applied. 
4. Double-check treatment calculations. Beware of confusion from mixing metric and 
standard units. 
5. Have aeration devices ready for use if needed. 
6. If treated water is to be discharged, make sure all appropriate permits are in place and 
regulatory authorities have been notified. 
7. If possible, conduct a bioassay on a small group of fish before treating the entire 
population in the rearing unit. 
When treating: 
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1. Dilute the regulated product with rearing water before applying it (or follow product 
directions). 
2. Ensure that the regulated product is well-mixed and evenly applied in the rearing 
units. 
3. Observe the fish closely and frequently during treatment for signs of distress. 
4. Monitor the temperature and dissolved-oxygen levels in the rearing unit during 
treatment. 
5. Except for oral treatments, discontinue feeding during treatment. Fish are unlikely to 
feed during treatment, and uneaten feed will foul the system and may reduce the 
efficacy of some treatments. 
6. Discontinue treatment and restore normal culture conditions if the fish become 
distressed. 
After treating: 
1. Observe the fish frequently for at least 24 hours following the treatment. 
2. Do not stress the treated fish for at least 48 hours. 
3. Recheck the fish to determine the efficacy of the treatment 
Judicious antibacterial use principles for veterinarians are discussed and concluded in Table 
9 (FDA, 2009). 
 
The food fish veterinarian should: 
1. Accept responsibility for helping clients design management, immunization, 
production unit and nutritional programmes that will reduce the incidence of disease 
and the need for antibacterial treatment. 
2. Use antibacterial drugs only within the confines of a valid veterinarian-client-patient 
relationship, including both the dispensing and issuing of prescriptions and 
veterinary feed directives. Extra-label usage should be consistent with regulatory 
agency laws, regulations and policies. 
3. Properly select and use antibacterial drugs. Veterinarians should participate in 
continuing education programmes that include therapeutics and the emergence 
and/or development of antibacterial resistance. 
4. Have strong clinical evidence of the identity of the disease’s aetiology, based upon 
history, clinical signs, necropsy, laboratory data, and/or past experience before 
recommending an antibacterial drug treatment. 
5. Treat food fish with antibacterial drugs according to the product label 
recommendations (including indication, dosage, duration, fish species and 
environmental conditions). 
6. Choose an antibacterial drug and treatment regimen based on the available 
laboratory and label (including package insert) information, additional data in the 
literature, and consideration of the pharmacokinetics, spectrum of activity and 
pharmacodynamics of the drug. 
7. Use antibacterial drugs with a specific clinical outcome(s) in mind, including a 
specific target for population morbidity and/or mortality-rate reduction. 
8. Specific outcome criteria will prevent an unnecessarily long therapy and indicate 
when the current therapy is no longer effective. 
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9. Determine the production population pathogen susceptibility at the first indication 
of increasing morbidity or mortality, and monitor the therapeutic response so as to 
detect changes in microbial susceptibility and in order to evaluate antibacterial 
selections. 
10. Routine necropsy examination of fish populations should be periodically performed, 
including antibacterial susceptibility testing and update historical information for 
developing treatment and control protocols. 
11. Use products that have the narrowest spectrum of activity and known effectiveness 
in vivo against the pathogen causing the disease problem. 
12. Choose antibacterial drugs of lesser importance in human medicine, if these receive 
future food fish use approval, and do not choose an antibacterial for which the 
emergence of resistance is expected in an advanced stage. 
13. Use, whenever possible, an antibacterial drug labelled to treat the condition 
diagnosed. 
14. Do not use combination antibacterial drug therapy unless there is information to 
show that this decreases or suppresses the target organism resistance development. 
15. Do not compound antibacterial drug formulations. 
16. Do not use antibacterial drugs to treat cases with a poor chance of recovery. 
17. Do not use antibacterial drugs prophylactically. 
18. Ensure proper on-farm drug use and protect antibacterial drug integrity through 
proper handling, storage and observation of the expiration date. 
19. Prescribe, dispense or write a Veterinary Feed Directive for drug quantities 
appropriate to the production-unit size and expected need using the approved 
formulation. 
20. Work with producers and/or facility fish health management personnel so as to 
ensure that farm personnel receive adequate training on the use of antibacterial 
drugs, including indications, diagnoses, dosages, withdrawal times, the route of 
administration, storage, handling and accurate record-keeping. 
21. Work closely with all other fish health experts involved in fish population health 
management at the fish production facility. 
Table 9. Judicious antibacterial use principles for veterinarians (resumed from (FDA, 
2009)).  
7. Conclusion 
The presence of disease in farmed fish populations has severe welfare implications for the 
affected fish, and poses a threat to the welfare of unaffected fish. Large quantities of 
antibacterials are used in aquaculture in some countries, often without professional 
consultation or supervision. Consequently, many problems are associated with the use of 
antibacterials in aquaculture. More research is needed in order to determine the 
consequences of the application of large quantities of antibacterials. Considering the rapid 
growth and importance of the aquaculture industry in many regions of the world and the 
widespread, intensive, and often unregulated use of antibacterial agents for animal 
production, additional efforts are required to prevent the development and spread of 
www.intechopen.com
 
Recent Advances in Fish Farms 
 
244 
antibacterial resistance in aquaculture. Also, safer, more effective medicines are necessary, 
along with improvements in husbandry and management which will reduce the need for 
those medicaments. However, without the use of veterinary medicines, aquaculture food 
production would be impaired. Furthermore, fish farmers and their veterinary surgeons 
must confirm that fish are kept in the best state of health and welfare. Governments, farmers 
and veterinary surgeons all have a shared responsibility to ensure that medicines are used 
judiciously. 
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